Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Allen-Auerbach

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Journal of Pediatric Hematology/Oncology|December 3, 2011
Is there a need for dedicated bone imaging in addition to 18F-FDG PET/CT imaging in pediatric sarcoma patients?Franziska Walter, Johannes Czernin, Theodore Hall, et al.
Pediatric Hematology and Oncology|September 23, 2011
18F-fluorodeoxyglucose uptake of bone and soft tissue sarcomas in pediatric patientsFranziska Walter, Noah Federman, Wipapat Apichairuk, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 3, 2007
Accuracy of PET/CT in characterization of solitary pulmonary lesionsShanna K Kim, Martin Allen-Auerbach, Jonathan Goldin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 25, 2012
Oncologic 18F-FDG PET/CT: referring physicians' point of viewDimitrios Karantanis, Dimitrios Kalkanis, Martin Allen-Auerbach, et al.
Nuclear Medicine Communications|September 10, 2016
The incidence of thyroid cancer in focal hypermetabolic thyroid lesions: an 18F-FDG PET/CT study in more than 6000 patientsMartin Barrio, Johannes Czernin, Michael W Yeh, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 30, 2013
(18)F-FDOPA PET for differentiating recurrent or progressive brain metastatic tumors from late or delayed radiation injury after radiation treatmentKarlo J Lizarraga, Martin Allen-Auerbach, Johannes Czernin, et al.
Annals of Nuclear Medicine|January 22, 2024
Visual and whole-body quantitative analyses of <sup>68</sup> Ga-DOTATATE PET/CT for prognosis of outcome after PRRT with <sup>177</sup>Lu-DOTATATEMasatoshi Hotta, Ida Sonni, Pan Thin, et al.
Molecular Imaging and Biology|June 27, 2019
Transforming an Academic Radiochemistry Facility for Positron Emission Tomography Drug cGMP ComplianceShaojun Zhu, Sherly Mosessian, Kurt Kroeger, et al.
Molecular Imaging and Biology|November 27, 2004
Comparison between 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography and positron emission tomography/computed tomography hardware fusion for staging of patients with lymphomaMartin Allen-Auerbach, Andrew Quon, Wolfgang A Weber, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 5, 2016
Human Biodistribution and Radiation Dosimetry of <sup>18</sup>F-Clofarabine, a PET Probe Targeting the Deoxyribonucleoside Salvage PathwayMartin J Barrio, Claudio Spick, Caius G Radu, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Journal of Pediatric Hematology/Oncology|December 3, 2011
Is there a need for dedicated bone imaging in addition to 18F-FDG PET/CT imaging in pediatric sarcoma patients?Franziska Walter, Johannes Czernin, Theodore Hall, et al.
Pediatric Hematology and Oncology|September 23, 2011
18F-fluorodeoxyglucose uptake of bone and soft tissue sarcomas in pediatric patientsFranziska Walter, Noah Federman, Wipapat Apichairuk, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 3, 2007
Accuracy of PET/CT in characterization of solitary pulmonary lesionsShanna K Kim, Martin Allen-Auerbach, Jonathan Goldin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 25, 2012
Oncologic 18F-FDG PET/CT: referring physicians' point of viewDimitrios Karantanis, Dimitrios Kalkanis, Martin Allen-Auerbach, et al.
Nuclear Medicine Communications|September 10, 2016
The incidence of thyroid cancer in focal hypermetabolic thyroid lesions: an 18F-FDG PET/CT study in more than 6000 patientsMartin Barrio, Johannes Czernin, Michael W Yeh, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 30, 2013
(18)F-FDOPA PET for differentiating recurrent or progressive brain metastatic tumors from late or delayed radiation injury after radiation treatmentKarlo J Lizarraga, Martin Allen-Auerbach, Johannes Czernin, et al.
Annals of Nuclear Medicine|January 22, 2024
Visual and whole-body quantitative analyses of <sup>68</sup> Ga-DOTATATE PET/CT for prognosis of outcome after PRRT with <sup>177</sup>Lu-DOTATATEMasatoshi Hotta, Ida Sonni, Pan Thin, et al.
Molecular Imaging and Biology|June 27, 2019
Transforming an Academic Radiochemistry Facility for Positron Emission Tomography Drug cGMP ComplianceShaojun Zhu, Sherly Mosessian, Kurt Kroeger, et al.
Molecular Imaging and Biology|November 27, 2004
Comparison between 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography and positron emission tomography/computed tomography hardware fusion for staging of patients with lymphomaMartin Allen-Auerbach, Andrew Quon, Wolfgang A Weber, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 5, 2016
Human Biodistribution and Radiation Dosimetry of <sup>18</sup>F-Clofarabine, a PET Probe Targeting the Deoxyribonucleoside Salvage PathwayMartin J Barrio, Claudio Spick, Caius G Radu, et al.
Pageof 5